Strasbourg and NCS join forces on new bioindustry courses

19 May 2009

France's Strasbourg University and North Carolina State University, USA, have entered into an agreement to collaborate on a unique set of  training capabilities for industry.

The Universitiy of Strasbourg and the Biomanufacturing Training and  Education Center of North Carolina State University began implementing  the agreement in May. It includes several types of cooperation,  including short courses to industry, shared certificates and exchange of  students, interns and faculty members.

To ensure training consistency, Strasbourg University will construct a  bioproduction training facility for initial and continuous training  similar to the BTEC facility in North Carolina. This will offer an  industrial environment in terms of equipment, ability to handle batches  of up to several hundred liters and industry-like processes.  Requalification training will also be offered to workers with a previous  industrial and manufacturing background from other industries.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight